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Sir,
We would like to clarify the results in ‘Excessive annual BMI
increase after chemotherapy among young survivors of testicular
cancer’ as a reply to Huddart et al’s Letter to the Editor.
In some agreement to Huddart et al’s results, our study showed
no influence of chemotherapy or any other treatment type on BMI
compared to our healthy control material (Controls). Our results
from the multivariate regression analysis indicated that in
survivors of testicular cancer (TCSs), chemotherapy had an impact
on the annual BMI increase independent of age and that the
surgery group displayed no significant annual BMI increase (Nord
et al, 2003). However, it only explained 8% of our observations as
compared to the normal population, thus indicating a multi-
factorial background for the annual BMI increase. In Huddart
et al’s publication, the comparison to an age-matched cohort from
the normal male population is lacking (Huddart et al, 2003). This
is important as we, indeed, did not find significant BMI increase
comparing the surgery group with the chemotherapy group. We
admit that it is a weakness in our study that so few other
explanatory factors were included in the regression analysis such
as gonadal hormones, smoking, exercise and eating habits, which
all have well-documented influences on BMI.
We still conclude that young TCSs, especially after chemother-
apy, are at risk of excessive annual BMI increase as compared to
the normal population (P¼0.013), but our results do not show any
impact on BMI, measured once in a cross-sectional study.
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